Current Oncology, Free Full-Text
Por um escritor misterioso
Last updated 17 junho 2024
Background: Information on immune responses in cancer patients following mRNA COVID-19 vaccines is still insufficient, but generally, patients had impaired serological responses, especially those with hematological malignancies. We evaluated serological response to COVID-19 mRNA vaccine in cancer patients receiving chemotherapy compared with healthy controls. Methods: In total, 195 cancer patients and 400 randomly selected controls who had been administered a Pfizer-BioNTech or Moderna COVID-19 vaccines in two doses were compared. The threshold of positivity was 4.33 BAU/mL. Patients were receiving anticancer treatment after the first and second dose of the vaccines. Results: a TOTAL OF 169 patients (87%) had solid tumors and 26 hemolymphopoietic diseases. Seropositivity rate was lower in patients than controls (91% vs. 96%), with an age/gender-adjusted rate ratio (RR) of 0.95 (95% CL = 0.89–1.02). Positivity was found in 97% of solid cancers and in 50% of hemolymphopoietic tumors. Both advanced and adjuvant therapy seemed to slightly reduce seropositivity rates in patients when compared to controls (RR = 0.97, 95% CL = 0.89–1.06; RR = 0.94, 95% CL = 0.87–1.01). Conclusions: the response to vaccination is similar in patients affected by solid tumors to controls. On the contrary, hemolymphopietic patients show a much lower response than controls.
K Pacs Workstation 2.5 Download - Colaboratory
Journal of Cancer Research and Clinical Oncology
PDF) Management of locally advanced breast cancer: Evolution and current practice
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer
Cancer
Oncoscience Freeing oncology from publication cost
PDF) Secular Trends in the Survival of Patients with Laryngeal Carcinoma, 1995–2007
Cancer - Wiley Online Library
The Nutrition and Living with Cancer Helpline - World Cancer Research Fund
Current advances of liquid biopsies in prostate cancer: Molecular biomarkers: Molecular Therapy - Oncolytics
Hallmarks of Cancer: The Next Generation: Cell
Breast Cancer Awareness Month
touchONCOLOGY - Online Education for Oncology Professionals
Current Oncology January 2023 - Browse Articles
Recomendado para você
-
Bronstein - Méier Mega Unidade17 junho 2024
-
Bronstein popular -_exames_a_preços_populares17 junho 2024
-
Bronstein Medicina Diagnóstica - Méier I (Megaunidade) - comentários, fotos, número de telefone e endereço - Centros médicos em Río de Janeiro17 junho 2024
-
Bronstein17 junho 2024
-
Kaplan-Meier estimates of melanoma-related mortality among 114 children17 junho 2024
-
Fra-1/AP-1 induces EMT in mammary epithelial cells by modulating Zeb1/2 and TGFβ expression17 junho 2024
-
Bronstein Medical Diagnostics - MÉIER - MEGA UNIDADE17 junho 2024
-
Biomedicines, Free Full-Text17 junho 2024
-
Bronstein Medicina Diagnóstica - Méier I (Megaunidade), R. Dias da Cruz, Rio de Janeiro - RJ17 junho 2024
-
Para presidente do Cremerj, redes de laboratórios não acompanharam17 junho 2024
você pode gostar
-
Códigos para GTA San Andreas (PS2) – Truques & Macetes17 junho 2024
-
Dino Run DX Steam CD Key Compre mais barato na Kinguin17 junho 2024
-
4 ideias típicas e simples de maquiagem de Halloween17 junho 2024
-
I Got a Cheat Skill in Another World and Became Unrivaled in the17 junho 2024
-
Códigos Ativos Reaper 2 (Novembro 2023) - One Gamer17 junho 2024
-
Chess Minimal for Nintendo Switch - Nintendo Official Site17 junho 2024
-
Mais três brasileiras confirmadas no Mundo Tênis Open, o WTA de Florianópolis - Lance!17 junho 2024
-
Light Novel Volume 4/Illustrations, Kaifuku Jutsushi no Yarinaoshi Wiki, Fandom17 junho 2024
-
The Daily Life of the Immortal King17 junho 2024
-
Basic Guide to Microsoft Word: Toolbars & Document Views - Video17 junho 2024